Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life-sciences and other industries, recently executed a contract services agreement with a well-known biotherapeutics firm. An article discussing the company reads, “Under the terms of the agreement, the firm will utilize PBIO’s proprietary BaroFold(TM) … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Agreement with Prominent Biotherapeutics Firm”
Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its receipt of two additional purchase orders for its revolutionary BaroShear(TM) K45 processing system. According to the update, the BaroShear K45, based on the company’s proprietary … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Receives Two New Purchase Orders for Revolutionary BaroShear K45 Processing System”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced financial results for the second quarter ended June 30, 2019, provided a business update, and offered guidance for the remainder of the fiscal year and for FY … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases Q2 2019 Financial Results, Provides Business Update”
Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, on Tuesday announced that it will host a teleconference to discuss its second quarter 2019 financial results and to provide a business update. The teleconference is scheduled for … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Teleconference to Discuss Q2 2019 Financial Results and Provide Business Update”
PBIO expects to achieve a significant revenue increase in 2019 and beyond through the expansion of its proprietary BaroFold platform into the estimated $44 billion global bioprocess technology market Over 200 therapeutic proteins and peptides are currently approved by the FDA for use with conditions such as cancer, immunological and metabolic disorders and infectious diseases … Continue reading “Pressure BioSciences Inc. (PBIO) Enters Contract Services Agreement with World-Renowned Biotherapeutics Firm”
Pressure BioSciences (OTCQB: PBIO) recently launched its BaroShear K45 system which is based on the company’s proprietary Ultra Shear Technology (“UST”) platform. The innovative system has been optimized for the unique purpose of producing high quality, water-soluble nanoemulsions of CBD oil in water (http://nnw.fm/Gr7D4). An article further discussing the company reads, “CBD, a non-psychoactive compound believed … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Solves CBD Water-Solubility Problem with Patented UST Platform”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, recently provided a working benchtop Ultra Shear Technology (“UST”) instrument to scientists at The Ohio State University. An article further discussing the company reads, “Dr. Edmund Y. Ting, senior … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Provides Proprietary Benchtop UST Instrument to Ohio State Scientists”
PBIO’s proprietary Ultra Shear Technology (UST) platform achieves the long sought-after ability to create truly water-soluble CBD oil that can provide optimized bioavailability CBD sales are projected to reach $89 billion by 2024 with a CAGR of 37 percent (2018-2024 forecast period) Analysts predict that the biggest short-term challenge for CBD businesses will be oversaturation … Continue reading “Pressure BioSciences Inc.’s (PBIO) Entry into CBD Market Aims Next-Gen Nanoemulsification Platform at Critical Water-Solubility Issues”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the initial sale of its revolutionary BaroShear(TM) K45 processing system. According to the update, the novel instrument system is based on the company’s proprietary Ultra Shear Technology(TM) … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces First Sale of the BaroShear K45, A Revolutionary Water-Soluble CBD Manufacturing System”
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced its entry into a contract services agreement with a multi-billion biotherapeutics company to enhance the manufacturing process of one of their candidate protein drugs. Per the update, … Continue reading “NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Second Major Contract Utilizing its BaroFold Technology Platform”
